InvestorsHub Logo
Followers 21
Posts 3570
Boards Moderated 0
Alias Born 12/18/2019

Re: JPG77 post# 196825

Tuesday, 12/14/2021 11:51:38 PM

Tuesday, December 14, 2021 11:51:38 PM

Post# of 233035
Company never claims they meet endpoints -- they just spin results to make them look good. GvHD failed. CoV CD10 and CD12 failed to meet any endpoints. Long CoV never met any statistical significance -- only spun for directional differences. Phase 1 mTNBC had no comparator and was just a dosing trial. Compassionate use is not a trial. NASH so far didn't have a comparator and they haven't reported the final open label data.

So far none of these have been claimed as statistically significant which is a requirement to meet endpoints and be approvable by FDA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News